Epilepside Klasik Ketojenik Diyet Dışı Diyet Tedavileri
Synopsis
Ketogenic diet (KD) is an important alternative treatment option in childhood drug-resistant epilepsies and metabolic disorders such as GLUT-1 or pyruvate dehydrogenase deficiency. Due to the strict rules (90% fat, 6% protein, 4% carbohydrate), patient non-compliance, and side effects of the classic ketogenic diet, more flexible alternative diet models have been developed over time. The first of these, the Medium-Chain Triglyceride (MCT) diet, provides faster ketosis by allowing higher protein and carbohydrate intake thanks to MCT fats that are rapidly absorbed without needing carnitine; however, it may cause gastrointestinal side effects such as abdominal cramps, diarrhea, and vomiting. Low Glycemic Index Treatment (LGIT) is a method with a ketogenic ratio of approximately 1:1, in which carbohydrate sources with a glycemic index below 50 are limited to 40-60 grams daily to maintain stable blood sugar levels for an anticonvulsant effect, without requiring food weighing or hospitalization. The Modified Atkins Diet (MAD) is an option without calorie, fluid, or protein restrictions, based on daily intake of 10-30 grams of carbohydrates and 60-70% fat, applicable in both children and adults, as effective as classic KD, and with high patient compliance. Evaluated for efficacy with an application of at least three months, these alternative ketogenic diet therapies are generally discontinued gradually and safely at the end of two years when seizure control is achieved.
References
Luat AF, Coyle L, Kamat D. The ketogenic diet: A practical guide for pediatricians. Pediatr Ann 2016;45(12):e446-50.
Kossoff EH, Zupec-Kania A, Rho JM. Ketogenic diets: an update for child neurologists. J Child Neurol 2009;24:979-988.
deCampo DM, Kossoff EH. Ketogenic dietary therapies for epilepsy and beyond. Curr Opin Clin Nutr Metab Care 2019;22(4):264-8.
Kosoff EH, Zupec-Kania BA, Auvin S, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 2018;3(2):175-92.
Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable child epilepsy. Neurology 1971;21:1097-1103.
Liu YM, Wang HS. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed J 2013;36:9-15.
Miranda MJ, Turner Z, Magrath G. Alternative diets to the classical ketogenic diet. Epilepsia 2008;49(Suppl 8):14-16.
Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet in the treatment of epilepsy in children: a randomised, controlled trial. Lancet Neurol 2008;7:500-506.
Sharma S, Jain P. The ketogenic diet and other dietary treatments for refractory epilepsy in children. Ann ndian Acad Neurol 2014;17:253-258.
Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet in the treatment of epilepsy in children: a randomised, controlled trial. Lancet Neurol 2008;7:500-506.
Neal EG, Cross JH. Efficacy of dietary treatments for epilepsy. J Hum Nutr Diet 2010;23:113-119.
Fitzimmons G, Sewell M. Ketogenic diets. In: Shaw V (Editor) Clinical Paediatric Dietetics. 4th ed. Chichester, West Susex: Wiley-Blackwell 2014:354-380.
Liu YM. Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia 2008;49(Suppl 8):33-36.
Neal E. The medium-chain triglyceride ketogenic diet. In: Neal E (Editor) Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. 1st ed. Chichester, West Sussex: Wiley-Black-well 2012:78-88.
Shaw V, Lawson M. Clinical Paediatric Dietetics. 3rd ed. British Journal of Nutrition 2007:604.
Pfeifer HH, Lyczkowski DA, Thiele EA. Low Glycemic index treatment: implementation and new insights into efficacy. Epilepsia 2008;49(Suppl 8):42-45.
Greene AE, Todorova MT, McGowan R, et al. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 2001;42:1371-8.
Huttenlocher PR. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 1976;10:536-40.
Kim SH, Kang HC, Lee EJ, et al. Low glycemic index treatment in patients with drug- resistant epilepsy. Brain Dev 2017;39(8):687-92.
Jenskins DJ, Wolever TM, Taylor RH, et al. Glycemic index of foods: a physiological basis for carbohydrate Exchange. AJCN 1981;34:362-366.
Pfeifer HH. The low glycemic index treatment, In: Neal E (editor) Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. 1st ed. Chichester, West Sussex: Wiley- Blackwell 2012:100-108.
Kosoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-basws therapies. Curr Opin Neurol 2012;25:173-178.
Miranda MJ, Turner Z, Magrath G. Alternative diets to the classical ketogenic diet- can we be more liberal? Epilepsy Res 2012;100:278-285.
Pfeifer HH. The low glycemic index treatment, In: Neal E (editor) Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. 1st ed. Chichester, West Sussex: Wiley- Blackwell 2012:100-108.
Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the international ketogenic diet study group. Epilepsia 2009;50:304-317.
Kosoff EH, Krauss GL, McGrogan JR et al. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology 2003;61:1789-1791.
Freeman JM, Vining EPG, Kossoff EH, et al. A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia 2009;50(2):322-5.
Chen W, Kossoff EH. Long-Term follow-up of children treated with the modified Atkins diet. J Child Neurol 2012;27(6):754-8.
Luat AF, Coyle L, Kamat D. The ketogenic diet: A practical guide for pediatricians. Pediatr Ann 2016;45(12):e446-50.
Sharma S, Jain P. The Modified Atkins Diet in Refractory Epilepsy. Epilepsy Res Treat 2014;2014:1-6.
Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia 2008;49(Suppl):37-41.
Kossoff EH, Dorward JL, Turner Z, et al. Prospective study of yhe Modified Atkins Diet in combination with a ketogenic liquid supplement during the initial month. J Child Neurol 2011;26:147-151.
Groesbeck DK, Bluml RM, Kossoff EH. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol 2006: 48: 978-981.
Worden LT, Turner Z, Pyzik PL, et al. Is there an ideal way to discontinue the ketogenic diet? Epilepsy Res 2011; 95: 232-236.
Roehl K, Sewak SL. Practice paper of the Academy of Nutrition and Dietetics: Classic and Modified Ketogenic Diets for Treatment of Epilepsy. J Acad Nutr Diet 2017; 117: 1279-1292.
Lambert B. Switching or discontinuing dietary treayment. In: Neal E (Editor) Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. 1st ed. Chichester, West Sussex: Wiley-Blackwell 2012: 172-178.